Loss of heterozygosity (LOH) on chromosome arm 17p is the most common genetic aberration in childhood primitive neuroectodermal tumors (PNETs). To determine the frequency and extent of 17p deletions, 29 loci on 17p were investigated in 24 tumors by using restriction fragment length polymorphism (RFLP) and microsatellite analysis. LOH on 17p was found in 9 of 24 tumors. In all tumors with LOH, a continuous stretch from the telomere to chromosome band 17p11.2 was completely deleted, and no interstitial or terminal small-scale deletions were detected in the remaining 15 tumors. In four tumors with LOH on 17p, the chromosomal breakpoint was located between D17S953 and D17S805. To identify this deletion breakpoint on the cytogenetic map of chromosome 17 and to exclude uniparental disomy, we verified our data by using fluorescence in situ hybridization (FISH) analyses. By using two yeast artificial chromosome (YAC) clones that were positive for D17S689 and D17S953, the same breakpoint was confirmed in two specimens of cerebrospinal fluid (CSF) metastases by using FISH on interphase preparations. We demonstrate that, in most childhood PNETs with LOH on 17p, the breakpoint is close to, but not within, the centromere. It varies, and it occurs predominantly between the two markers D17S689 and D17S953, which is an unstable chromosomal region that is deleted or duplicated in the Smith-Magenis syndrome. Because LOH of 17p is associated with the formation of isochromosome 17q in the majority of PNETs, this study provides entry points to determine the molecular nature of this phenomenon.

Download full-text PDF

Source
http://dx.doi.org/10.1002/(sici)1098-2264(199701)18:1<50::aid-gcc6>3.0.co;2-0DOI Listing

Publication Analysis

Top Keywords

loh 17p
16
chromosome arm
8
17p
8
arm 17p
8
childhood primitive
8
primitive neuroectodermal
8
neuroectodermal tumors
8
chromosome band
8
band 17p112
8
tumors tumors
8

Similar Publications

Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

Biomed Pharmacother

April 2024

Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia. Electronic address:

Article Synopsis
  • Tumour suppressor genes are crucial in the development of lung cancer, which is a common type of cancer that often shows resistance to initial treatment.
  • Extensive research has been focused on understanding how mutations in these genes lead to cancer progression and treatment failure, particularly looking at specific chromosomal areas vulnerable to loss of heterozygosity (LOH) due to genetic and environmental factors.
  • The review aims to provide insight into the molecular mechanisms behind these alterations and to inspire future research efforts for more effective lung cancer therapies.
View Article and Find Full Text PDF

Molecular landscape of proliferative verrucous leukoplakia: a systematic review.

Br J Oral Maxillofac Surg

February 2024

Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Institute for Life Sciences, University of Southampton, Southampton, UK.

Article Synopsis
  • Proliferative verrucous leukoplakia (PVL) is a rare oral condition with a potential to evolve into oral cancers, lacking predictive biomarkers for its progression.
  • A review of 685 cases revealed PVL’s genomic profile includes initial high loss of heterozygosity (LOH) and low copy number alterations, with later mutations found in specific genes but no TP53 mutations.
  • Differences in LOH and specific chromosomal deletions and amplifications suggest similarities with oral verrucous carcinoma (OVC) and oral squamous cell carcinoma (OSCC), indicating a need for further research to clarify PVL's genomic landscape.
View Article and Find Full Text PDF

Background: Recently, HER2-negative breast cancers have been reclassified by protein expression into 'HER2-low' and 'HER2-zero' subgroups, but the consideration of HER2-low breast cancer as a distinct biological subtype with differing prognoses remains controversial. By contrast, non-neutral copy number alteration (CNA) status is associated with inferior survival outcomes compared to CNA-neutral breast cancer, providing an alternative approach to classification.

Methods: Here, we investigated the molecular landscape of non-metastatic HER2-negative BCs in relation to CNA status to elucidate biological differences.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the impact of the t(11;14) genetic anomaly in multiple myeloma patients to guide future treatment strategies.
  • Researchers examined data from 74 patients with t(11;14), comparing them to two other groups with different genetic profiles (IgH HR-MM and Hyperdiploid-MM), finding no significant differences in demographics or initial treatment patterns.
  • While overall progression-free survival was similar across groups, patients with t(11;14) showed poorer outcomes, highlighting the potential for using targeted therapies like venetoclax to improve treatment effectiveness for these patients.
View Article and Find Full Text PDF

Background: Research suggests physicians may harbour paternalistic attitudes towards people with intellectual and developmental disabilities and lack the knowledge and skills to work with them. This study examined the impact of a brief intellectual and developmental disability curriculum intervention on these outcomes.

Methods: First-year medical students completed a pre-post questionnaire on attitudes and knowledge of intellectual and developmental disabilities in conjunction with a curriculum (a virtual tour of a developmental service site; panel discussions; tutorial presentations).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!